ATE141286T1 - Hiv-peptide, künstliche hiv-antigene und immuntestsätze - Google Patents

Hiv-peptide, künstliche hiv-antigene und immuntestsätze

Info

Publication number
ATE141286T1
ATE141286T1 AT88909626T AT88909626T ATE141286T1 AT E141286 T1 ATE141286 T1 AT E141286T1 AT 88909626 T AT88909626 T AT 88909626T AT 88909626 T AT88909626 T AT 88909626T AT E141286 T1 ATE141286 T1 AT E141286T1
Authority
AT
Austria
Prior art keywords
hiv
artificial
pct
antigen
epitope
Prior art date
Application number
AT88909626T
Other languages
English (en)
Inventor
Jerzy Trojnar
Brita Wahren
Ulla Ruden
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20370026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE141286(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Ab filed Critical Ferring Ab
Application granted granted Critical
Publication of ATE141286T1 publication Critical patent/ATE141286T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT88909626T 1987-10-28 1988-10-27 Hiv-peptide, künstliche hiv-antigene und immuntestsätze ATE141286T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8704185A SE8704185L (sv) 1987-10-28 1987-10-28 Nya peptider, artificiella antigener och immunoanalystestsatser

Publications (1)

Publication Number Publication Date
ATE141286T1 true ATE141286T1 (de) 1996-08-15

Family

ID=20370026

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88909626T ATE141286T1 (de) 1987-10-28 1988-10-27 Hiv-peptide, künstliche hiv-antigene und immuntestsätze

Country Status (11)

Country Link
US (1) US5981170A (de)
EP (1) EP0396559B1 (de)
JP (2) JP2818797B2 (de)
AT (1) ATE141286T1 (de)
DE (1) DE3855479T2 (de)
DK (1) DK104590A (de)
FI (1) FI902143A0 (de)
IL (1) IL88224A0 (de)
NO (1) NO302369B1 (de)
SE (1) SE8704185L (de)
WO (1) WO1989003844A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
IL88963A (en) * 1988-01-27 1996-05-14 Iaf Biochem Int Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6214537B1 (en) 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6248574B1 (en) * 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
DE69129207T2 (de) * 1990-01-16 1998-10-08 Orgenics Ltd Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
CA2078545A1 (en) * 1990-04-03 1991-10-04 Timothy J. Gregory Hiv envelope polypeptides
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
US6277824B1 (en) * 1998-07-10 2001-08-21 Adherex Technologies Compounds and methods for modulating adhesion molecule function
CA2350911A1 (en) 1998-11-16 2000-05-25 Board Of Regents, The University Of Texas System Hiv-specific t-cell induction
US7094884B2 (en) 2001-06-22 2006-08-22 Roche Diagnostics Corporation Soluble complexes of amylod β peptide and peptidyl prolyl isomerase chaperone and methods of making and using them
ATE522603T1 (de) 2001-06-22 2011-09-15 Hoffmann La Roche Löslicher komplex, der retrovirale oberflächen- glykoproteine und fkpa oder slyd enthält
US7094757B2 (en) 2001-06-22 2006-08-22 Roche Diagnostics Corporation Complexes comprising a prion protein and a peptidyl prolyl isomerase chaperone, and method for producing and using them
US6962982B2 (en) 2001-06-22 2005-11-08 Roche Diagnostics Corporation Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them
US7615530B2 (en) * 2003-08-29 2009-11-10 Artificial Cell Technologies, Inc. Immunogenic compositions and methods of use
EP1681568A1 (de) * 2003-10-29 2006-07-19 Hidechika Okada Künstlicher antikörper mit komplementärem peptid
CA2627376C (en) * 2005-10-25 2016-07-05 Donald Templeton Haynie Immunogenic compositions and methods of use
US7723294B2 (en) * 2007-04-02 2010-05-25 Artificial Cell Technologies, Inc. Polypeptide films and methods
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
WO2012170765A2 (en) 2011-06-10 2012-12-13 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650175T3 (de) * 1985-04-29 2007-09-06 Bio-Rad Laboratories, Inc., Hercules Synthetische antigene zum nachweis von aids.
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
US4735896A (en) * 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
DE3788397T3 (de) * 1986-03-24 2003-11-27 Ortho Pharma Corp Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
DE3789633T2 (de) * 1986-05-27 1994-08-04 Hoffmann La Roche HTLV-III(LAV)Decke-Peptide.
US4957737A (en) * 1986-05-27 1990-09-18 Hoffmann-La Roche Inc. HTLV-III (LAV) envelope peptides
US4812556A (en) * 1987-05-18 1989-03-14 Virovahl Synthetic peptide antigen for the detection of HIV-2 infection
DE3901857A1 (de) * 1989-01-23 1990-07-26 Boehringer Mannheim Gmbh Verfahren zur bestimmung von hiv 2 antikoerpern

Also Published As

Publication number Publication date
NO901899D0 (no) 1990-04-27
NO901899L (no) 1990-04-27
IL88224A0 (en) 1989-06-30
NO302369B1 (no) 1998-02-23
JPH10101697A (ja) 1998-04-21
SE8704185D0 (sv) 1987-10-28
US5981170A (en) 1999-11-09
JP2818797B2 (ja) 1998-10-30
DE3855479T2 (de) 1997-01-02
EP0396559B1 (de) 1996-08-14
SE8704185L (sv) 1989-04-29
EP0396559A1 (de) 1990-11-14
FI902143A0 (fi) 1990-04-27
DE3855479D1 (de) 1996-09-19
WO1989003844A1 (en) 1989-05-05
JPH03500648A (ja) 1991-02-14
DK104590A (da) 1990-06-26
DK104590D0 (da) 1990-04-27
JP3231666B2 (ja) 2001-11-26

Similar Documents

Publication Publication Date Title
ATE141286T1 (de) Hiv-peptide, künstliche hiv-antigene und immuntestsätze
ATE114672T1 (de) Peptidzusammensetzung und verfahren zum nachweis von antikörpern gegen htlv-iii.
HUP0303134A2 (hu) HIV-peptidek, antigének, vakcinakészítmények, immunológiai mérési reagenskészletek és eljárás HIV által indukált antitestek detektálására
DE68923882D1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
Child et al. A review of the applications of immunochemistry to archaeological bone
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
Obinata et al. Immunochemical comparison of myosin light chains from chicken fast white, slow red, and cardiac muscle
KR870011154A (ko) Htlv-iii바이러스 관련 펩티드, 이에 대한 항체, 백신, aids 바이러스에 대한 수동 및 자동 면역 및 aids 바이러스의 혈청학적 진단을 위한 진단시험
KR920702688A (ko) Htlv-1 감염의 진단, 치료 및 왁찐 접종용 펩타이드 및 그것으로 부터 유도된 항체
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
SE9000595L (sv) Nya peptider, diagnostiska antigener och ett immunanalysfoerfarande
DE69015708T2 (de) Künstliche peptid-zusammensetzungen mit immunoreaktiven antikörpern von htlv-1.
FI913714A (fi) Peptider med foer a 1-mikroglobulin karakteristiska antigeniska determinanter.
SE8901566D0 (sv) Nya peptider inkluderande en disulfidbindning
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
KR910007962A (ko) Hiv 관련 펩티드
ATE80895T1 (de) Bordetella pertussis-polypeptide und toxinantigene.
Winsnes Quantification of Tetanus Antitoxin in Human Sera: I. Counter‐Immunoelectrophoresis
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee